While preclinical data is promising, its important to recognize that neither peptide is FDA-approved for human therapeutic use, and most evidence is derived from animal or laboratory studies
Factors that may trigger perioral dermatitis include the following: Drugs: steroid creams, ointments, and inhalers Fluorinated toothpaste Skincare lotions and creams, especially those containing petroleum jelly, paraffin base, and isopropyl myristate Sunscreens Makeup products Certain scented skincare products Ultraviolet (UV) light Heat Dust Wind Certain infections Oral contraceptives Hormones Vitamin B12 deficiency What are the signs of perioral dermatitis
It identified no adequate acute, repeat-dose, genotoxicity, reproductive-toxicity or carcinogenicity programme
BNIP3, BCL2 and adenovirus E1B 19-kDa-interacting protein 3
BPC-157 Category Regenerative Research CAS Number 137525-51-0 Form Factor Lyophilized Powder BPC-157 is a synthetic pentadecapeptide sequence derived from a partial sequence found in gastric juice protein
An FDA advisory committee recently recommended they be considered for compounding, meaning pharmacies may be allowed to prepare them with a doctors prescription